Dr. David Friend, managing director and chief transformation officer of the BDO Center for Healthcare Excellence and Innovation talks about developing models and measurements for value-based care as a method to lower drug prices with Ann Kraft, executive director of Purdue Pharma, and Dr. Steven Small, professor of Neurology, Neurobiology and Anatomy, and Cognitive Sciences, and chief scientific officer of the Medical Innovation Institute at the School of Medicine of the University of California, Irvine.

Tune in to the full episode to hear about:

• The challenges involved in developing a model for value-based care
• How tying drug pricing to value-based care affects pharmaceutical company incentives
• How new technologies will come into play
• What problems exist with research and data collection